• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In response to "who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies".

作者信息

McGarry Meghan E, McColley Susanna A, Taylor-Cousar Jennifer

机构信息

Department of Pediatrics, University of California San Francisco, United States.

Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, United States.

出版信息

Respir Med. 2022 Oct;202:106953. doi: 10.1016/j.rmed.2022.106953. Epub 2022 Aug 22.

DOI:10.1016/j.rmed.2022.106953
PMID:36049345
Abstract
摘要

相似文献

1
In response to "who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies".针对“那10%是谁？——囊性纤维化（CF）患者无资格接受高效调节剂疗法”
Respir Med. 2022 Oct;202:106953. doi: 10.1016/j.rmed.2022.106953. Epub 2022 Aug 22.
2
Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey.适合调节剂药物的患者：来自土耳其囊性纤维化登记处的数据。
Pediatr Pulmonol. 2020 Sep;55(9):2302-2306. doi: 10.1002/ppul.24854. Epub 2020 May 26.
3
A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants.婴儿囊性纤维化及囊性纤维化跨膜传导调节因子调节剂试验的新时代。
Am J Respir Crit Care Med. 2022 Nov 15;206(10):1193-1195. doi: 10.1164/rccm.202207-1356ED.
4
New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.调节和纠正囊性纤维化跨膜传导调节因子的新治疗方法。
Pediatr Clin North Am. 2016 Aug;63(4):751-64. doi: 10.1016/j.pcl.2016.04.006.
5
The Future of Highly Effective Modulator Therapy in Cystic Fibrosis.囊性纤维化中高效调节剂疗法的未来
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1453-1455. doi: 10.1164/rccm.202104-0850ED.
6
The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis.高效囊性纤维化跨膜电导调节剂调节剂对女性囊性纤维化患者健康的影响。
Clin Ther. 2023 Mar;45(3):278-289. doi: 10.1016/j.clinthera.2023.01.016. Epub 2023 Feb 24.
7
Patient personalized translational tools in cystic fibrosis to transform data from bench to bed-side and back.囊性纤维化患者个体化转化工具，将数据从基础研究转化到临床应用并反馈回来。
Am J Physiol Gastrointest Liver Physiol. 2021 Jun 1;320(6):G1123-G1130. doi: 10.1152/ajpgi.00095.2021. Epub 2021 May 5.
8
Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies.囊性纤维化跨膜转导调节因子增效剂作为有前途的囊性纤维化治疗方法。
Expert Opin Investig Drugs. 2011 Mar;20(3):423-5. doi: 10.1517/13543784.2011.554823. Epub 2011 Feb 9.
9
Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?“现实生活”中的囊性纤维化跨膜传导调节因子生物标志物：我们能否评估囊性纤维化跨膜传导调节因子疗法的个体疗效？
Ther Adv Respir Dis. 2015 Aug;9(4):198-200. doi: 10.1177/1753465815579364.
10
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.囊性纤维化跨膜电导调节剂调节剂治疗：耳鼻喉科医生的综述。
Am J Rhinol Allergy. 2020 Jul;34(4):573-580. doi: 10.1177/1945892420912368. Epub 2020 Mar 13.

引用本文的文献

1
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective.推进囊性纤维化临床试验管道：具有全球试验网络视角的新路线图。
Lancet Respir Med. 2023 Oct;11(10):932-944. doi: 10.1016/S2213-2600(23)00297-7. Epub 2023 Sep 9.